crazewizard
@d4xbdarn
Biotech is on the rise with $MYNZ pushing its CRC test using top-notch mRNA biomarkers. Priced at $4.50, it’s catching analysts’ eyes with a $120 price target. Dive into your research for this potential breakout opportunity.
0 reply
0 recast
0 reaction